These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 7654939)

  • 21. [A novel mutation causes congenital factor V deficiency].
    Hou LH; Xie F; Liu XE; Zhang L; Guo YL; Dong CX; Li ZT; Yang B; Yang LH
    Zhonghua Xue Ye Xue Za Zhi; 2003 Sep; 24(9):455-9. PubMed ID: 14575586
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Arg506 --> Gln mutation of coagulation factor V (factor V Leiden) and transient cerebral ischemia at a young age in 3 members of the same family].
    Moia M; La Spina I; Padalino R; Carpenedo M
    Ann Ital Med Int; 1996; 11(1):17-9. PubMed ID: 8645525
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Activated protein C resistance and thrombosis: molecular mechanisms of hypercoagulable state due to FVR506Q mutation.
    Dahlbäck B
    Semin Thromb Hemost; 1999; 25(3):273-89. PubMed ID: 10443959
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Factor-V (Arg506 --> Gln) mutation in ischemic cerebrovascular disease.
    Iniesta JA; Corral J; Fernández-Pardo J; González-Conejero R; Vicente V
    Haemostasis; 1997; 27(3):105-11. PubMed ID: 9306126
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Coagulation factor V (Arg506-->Gln) mutation and early saphenous vein graft occlusion after coronary artery bypass grafting.
    Moor E; Silveira A; van't Hooft F; Tornvall P; Blombäck M; Wiman B; Rydén L; Hamsten A
    Thromb Haemost; 1998 Aug; 80(2):220-4. PubMed ID: 9716141
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Thrombophilia as a multigenic disease.
    Zöller B; García de Frutos P; Hillarp A; Dahlbäck B
    Haematologica; 1999 Jan; 84(1):59-70. PubMed ID: 10091393
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Unexplained thrombosis and factor V Leiden mutation.
    Alhenc-Gelos M; Gandrille S; Aubry ML; Emmerich J; Flessinger JN; Aiach M
    Lancet; 1994 Aug; 344(8921):555-6. PubMed ID: 7914654
    [No Abstract]   [Full Text] [Related]  

  • 28. Thrombosis in otherwise well children with the factor V Leiden mutation.
    Sifontes MT; Nuss R; Jacobson LJ; Griffin JH; Manco-Johnson MJ
    J Pediatr; 1996 Mar; 128(3):324-8. PubMed ID: 8774498
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Familial coagulation factor V deficiency caused by a novel 4 base pair insertion in the factor V gene: factor V Stanford [erratum].
    Zehnder JL; Hiraki DD; Jones CD; Gross N; Grumet FC
    Thromb Haemost; 1999 Nov; 82(5):XII. PubMed ID: 10681265
    [No Abstract]   [Full Text] [Related]  

  • 30. Cross-linking hybridization assay for direct detection of factor V Leiden mutation.
    Zehnder J; Van Atta R; Jones C; Sussman H; Wood M
    Clin Chem; 1997 Sep; 43(9):1703-8. PubMed ID: 9299963
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Resistance to activated protein C due to mutated factor V as a novel cause of inherited thrombophilia.
    De Stefano V; Leone G
    Haematologica; 1995; 80(4):344-56. PubMed ID: 7590506
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Rapid detection of factor V Leiden (FVQ506) by non-radioactive single strand conformation polymorphism (SSCP).
    Arruda VR; von Zuben PM; Annichino-Bizzachi JM; Costa FF
    Sangre (Barc); 1996 Oct; 41(5):379-81. PubMed ID: 8986114
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The factor V Leiden mutation which predisposes to thrombosis is not common in patients with antiphospholipid syndrome.
    Dizon-Townson D; Hutchison C; Silver R; Branch DW; Ward K
    Thromb Haemost; 1995 Oct; 74(4):1029-31. PubMed ID: 8560406
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Rapid genotyping of factor V Leiden mutation using single-tube bidirectional allele-specific amplification and automated ultrathin-layer agarose gel electrophoresis.
    Sasvari-Szekely M; Gerstner A; Ronai Z; Staub M; Guttman A
    Electrophoresis; 2000 Mar; 21(4):816-21. PubMed ID: 10733227
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Semi-automated detection of the factor V mutation by allele specific amplification and capillary electrophoresis.
    van de Locht LT; Kuypers AW; Verbruggen BW; Linssen PC; Nováková IR; Mensink EJ
    Thromb Haemost; 1995 Nov; 74(5):1276-9. PubMed ID: 8607109
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification of the same factor V gene mutation in 47 out of 50 thrombosis-prone families with inherited resistance to activated protein C.
    Zöller B; Svensson PJ; He X; Dahlbäck B
    J Clin Invest; 1994 Dec; 94(6):2521-4. PubMed ID: 7989612
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Elevated levels of soluble thrombomodulin in plasma from children with Arg 506 to Gln mutation in the factor V gene.
    Nowak-Göttl U; Vielhaber H
    Eur J Haematol; 1997 Jan; 58(1):51-5. PubMed ID: 9020374
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Identification of two novel mutations of human blood coagulation factor V gene in a Chinese family with congenital factor V deficiency].
    Zheng WD; Liu YH; Liu HF; Chen ZH; Wang Y
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2006 Oct; 23(5):515-8. PubMed ID: 17029198
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Molecular characterization of a type I quantitative factor V deficiency in a thrombosis patient that is "pseudo homozygous" for activated protein C resistance.
    Guasch JF; Lensen RP; Bertina RM
    Thromb Haemost; 1997 Feb; 77(2):252-7. PubMed ID: 9157576
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Factor V gene mutation is a risk factor for cerebral venous thrombosis.
    Martinelli I; Landi G; Merati G; Cella R; Tosetto A; Mannucci PM
    Thromb Haemost; 1996 Mar; 75(3):393-4. PubMed ID: 8701395
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.